Factors determining sensitivity or resistance of tumor cell lines towards artesunate

Clinical oncology is still challenged by the development of drug resistance of tumors that result in poor prognosis for patients. There is an urgent necessity to understand the molecular mechanisms of resistance and to develop novel therapy strategies. Artesunate (ART) is an anti-malarial drug, whic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sertel, Serkan (VerfasserIn) , Eichhorn, Tolga (VerfasserIn) , Sieber, Sebastian (VerfasserIn) , Sauer, Alexandra (VerfasserIn) , Weiß, Johanna (VerfasserIn) , Plinkert, Peter K. (VerfasserIn) , Efferth, Thomas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 6 February 2010
In: Chemico-biological interactions
Year: 2010, Jahrgang: 185, Heft: 1, Pages: 42-52
ISSN:1872-7786
DOI:10.1016/j.cbi.2010.02.002
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.cbi.2010.02.002
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0009279710000700
Volltext
Verfasserangaben:Serkan Sertel, Tolga Eichhorn, Sebastian Sieber, Alexandra Sauer, Johanna Weiss, Peter K. Plinkert, Thomas Efferth

MARC

LEADER 00000caa a2200000 c 4500
001 1851100156
003 DE-627
005 20230710125330.0
007 cr uuu---uuuuu
008 230627s2010 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.cbi.2010.02.002  |2 doi 
035 |a (DE-627)1851100156 
035 |a (DE-599)KXP1851100156 
035 |a (OCoLC)1389793698 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Sertel, Serkan  |d 1974-  |e VerfasserIn  |0 (DE-588)173510221  |0 (DE-627)698422635  |0 (DE-576)134355059  |4 aut 
245 1 0 |a Factors determining sensitivity or resistance of tumor cell lines towards artesunate  |c Serkan Sertel, Tolga Eichhorn, Sebastian Sieber, Alexandra Sauer, Johanna Weiss, Peter K. Plinkert, Thomas Efferth 
264 1 |c 6 February 2010 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 27.06.2023 
520 |a Clinical oncology is still challenged by the development of drug resistance of tumors that result in poor prognosis for patients. There is an urgent necessity to understand the molecular mechanisms of resistance and to develop novel therapy strategies. Artesunate (ART) is an anti-malarial drug, which also exerts profound cytotoxic activity towards cancer cells. We first applied a gene-hunting approach using cluster and COMPARE analyses of microarray-based transcriptome-wide mRNA expression profiles. Among the genes identified by this approach were genes from diverse functional groups such as structural constituents of ribosomes (RPL6, RPL7, RPS12, RPS15A), kinases (CABC1, CCT2, RPL41), transcriptional and translational regulators (SFRS2, TUFM, ZBTB4), signal transducers (FLNA), control of cell growth and proliferation (RPS6), angiogenesis promoting factors (ITGB1), and others (SLC25A19, NCKAP1, BST1, DBH, FZD7, NACA, MTHFD2). Furthermore, we applied a candidate gene approach and tested the role of resistance mechanisms towards established anti-cancer drugs for ART resistance. By using transfected or knockout cell models we found that the tumor suppressor p16INK4A and the anti-oxidant protein, catalase, conferred resistance towards ART, while the oncogene HPV-E6 conferred sensitivity towards ART. The tumor suppressor p53 and its downstream protein, p21, as well as the anti-oxidant manganese-dependent superoxide dismutase did not affect cellular response to ART. In conclusion, our pharmacogenomic approach revealed that response of tumor cells towards ART is multi-factorial and is determined by gene expression associated with either ART sensitivity or resistance. At least some of the functional groups of genes (e.g. angiogenesis promoting factors, cell growth and proliferation-associated genes signal transducers and kinases) are also implicated in clinical responsiveness of tumors towards chemotherapy. It merits further investigation, whether ART is responsive in clinically refractory tumors and whether the genes identified in the present study also determine clinical responsiveness towards ART. 
650 4 |a Anti-cancer therapy 
650 4 |a Artemisinin 
650 4 |a Artesunate (ART) 
650 4 |a Molecular pharmacology 
650 4 |a Multidrug resistance (MDR) 
650 4 |a Natural products 
650 4 |a Pharmacogenomics 
650 4 |a Traditional Chinese medicine (TCM) 
700 1 |a Eichhorn, Tolga  |e VerfasserIn  |0 (DE-588)1013170261  |0 (DE-627)663816157  |0 (DE-576)346649714  |4 aut 
700 1 |a Sieber, Sebastian  |d 1978-  |e VerfasserIn  |0 (DE-588)1024149102  |0 (DE-627)719250811  |0 (DE-576)368017087  |4 aut 
700 1 |a Sauer, Alexandra  |e VerfasserIn  |0 (DE-588)1076127886  |0 (DE-627)834448025  |0 (DE-576)444967958  |4 aut 
700 1 |a Weiß, Johanna  |e VerfasserIn  |0 (DE-588)1050230906  |0 (DE-627)783666322  |0 (DE-576)404441114  |4 aut 
700 1 |a Plinkert, Peter K.  |e VerfasserIn  |0 (DE-588)1032658509  |0 (DE-627)739933043  |0 (DE-576)169008908  |4 aut 
700 1 |a Efferth, Thomas  |d 1960-  |e VerfasserIn  |0 (DE-588)112533116  |0 (DE-627)527709158  |0 (DE-576)167480634  |4 aut 
773 0 8 |i Enthalten in  |t Chemico-biological interactions  |d Amsterdam [u.a.] : Elsevier Science, 1969  |g 185(2010), 1, Seite 42-52  |h Online-Ressource  |w (DE-627)306353911  |w (DE-600)1496834-4  |w (DE-576)255530633  |x 1872-7786  |7 nnas  |a Factors determining sensitivity or resistance of tumor cell lines towards artesunate 
773 1 8 |g volume:185  |g year:2010  |g number:1  |g pages:42-52  |g extent:11  |a Factors determining sensitivity or resistance of tumor cell lines towards artesunate 
856 4 0 |u https://doi.org/10.1016/j.cbi.2010.02.002  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0009279710000700  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230627 
993 |a Article 
994 |a 2010 
998 |g 1032658509  |a Plinkert, Peter K.  |m 1032658509:Plinkert, Peter K.  |d 910000  |d 911000  |e 910000PP1032658509  |e 911000PP1032658509  |k 0/910000/  |k 1/910000/911000/  |p 6 
998 |g 1050230906  |a Weiß, Johanna  |m 1050230906:Weiß, Johanna  |d 910000  |d 910100  |d 50000  |e 910000PW1050230906  |e 910100PW1050230906  |e 50000PW1050230906  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 5 
998 |g 1013170261  |a Eichhorn, Tolga  |m 1013170261:Eichhorn, Tolga  |d 140000  |e 140000PE1013170261  |k 0/140000/  |p 2 
998 |g 173510221  |a Sertel, Serkan  |m 173510221:Sertel, Serkan  |d 910000  |d 911000  |e 910000PS173510221  |e 911000PS173510221  |k 0/910000/  |k 1/910000/911000/  |p 1  |x j 
999 |a KXP-PPN1851100156  |e 4343987582 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"11 S."}],"name":{"displayForm":["Serkan Sertel, Tolga Eichhorn, Sebastian Sieber, Alexandra Sauer, Johanna Weiss, Peter K. Plinkert, Thomas Efferth"]},"recId":"1851100156","id":{"doi":["10.1016/j.cbi.2010.02.002"],"eki":["1851100156"]},"relHost":[{"disp":"Factors determining sensitivity or resistance of tumor cell lines towards artesunateChemico-biological interactions","part":{"year":"2010","text":"185(2010), 1, Seite 42-52","pages":"42-52","extent":"11","volume":"185","issue":"1"},"note":["Gesehen am 04.02.20"],"title":[{"title":"Chemico-biological interactions","title_sort":"Chemico-biological interactions","subtitle":"a journal of molecular and biochemical toxicology"}],"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedDisp":"1969-","dateIssuedKey":"1969","publisher":"Elsevier Science"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"306353911","pubHistory":["1.1969 -"],"id":{"eki":["306353911"],"issn":["1872-7786"],"zdb":["1496834-4"]}}],"person":[{"role":"aut","given":"Serkan","display":"Sertel, Serkan","family":"Sertel"},{"given":"Tolga","role":"aut","display":"Eichhorn, Tolga","family":"Eichhorn"},{"given":"Sebastian","role":"aut","family":"Sieber","display":"Sieber, Sebastian"},{"family":"Sauer","display":"Sauer, Alexandra","role":"aut","given":"Alexandra"},{"display":"Weiß, Johanna","family":"Weiß","given":"Johanna","role":"aut"},{"role":"aut","given":"Peter K.","family":"Plinkert","display":"Plinkert, Peter K."},{"role":"aut","given":"Thomas","family":"Efferth","display":"Efferth, Thomas"}],"title":[{"title_sort":"Factors determining sensitivity or resistance of tumor cell lines towards artesunate","title":"Factors determining sensitivity or resistance of tumor cell lines towards artesunate"}],"note":["Gesehen am 27.06.2023"],"origin":[{"dateIssuedKey":"2010","dateIssuedDisp":"6 February 2010"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"]} 
SRT |a SERTELSERKFACTORSDET6201